Mechanisms That Mediate The Absence of Lymphatics in the Retina

调节视网膜淋巴管缺失的机制

基本信息

  • 批准号:
    7458430
  • 负责人:
  • 金额:
    $ 30.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The lymphatic system plays a dual role: 1) draining interstitial fluid from tissues and returning it to the blood and, 2) participating in the immune response. All vascularized tissues, except the central nervous system (CNS), are invested with lymphatic vessels. Although significant progress has recently been made in understanding the molecules that regulate lymphangiogenesis, very little is known about factors or conditions that deter lymphatic growth. We, thus, propose to investigate this question and to test the hypothesis that the absence of lymphatic vessels in the CNS is the result of an active inhibitory process. We propose that suppression of lymphatic vessels in the CNS is mediated by Sema3F binding to NRP2, which acts to block the pro-lymphatic effects of VEGF-C and VEGF-D. We propose to test this hypothesis with the following aims three aims. (1) To examine the expression of Sema3F, NRP2 and VEGF-C in the retina and to further characterize the lymphatic-like structures in the retina. Sema3F and 3B will be examined by in situ hybridization in postnatal mouse retinas and in the adult. NRP2 expression will be assessed using NRP2-LacZ mice and by in situ hybridization. Lymphatic-like structures will be examined over time, beginning at P0, and will be assessed for expression of other lymphatic markers, including NRP2, VEGFR3, podoplanin and Prox-1. (2) To determine if blocking Sema3F leads to the formation of lymphatic vessels in the retina. The action of Sema3F will be neutralized by administration of soluble NRP2 or neutralizing Sema3F. In addition, the effect of VEGF- C overexpression will be assessed. (3) To determine if the Sema3F administration can suppress lymphangiogenesis in a model of corneal inflammation/wound healing. The ability of Sema3F to block the formation of lymphatic vessels outside of the retina will be examined by injection of Sema3F protein in a well-characterized corneal suture model.
描述(申请人提供):淋巴系统起双重作用:1)从组织中排出间质液体并将其返回血液;2)参与免疫反应。除中枢神经系统(CNS)外,所有有血管的组织都有淋巴管。尽管最近在了解调节淋巴管生成的分子方面取得了重大进展,但对阻止淋巴管生长的因素或条件知之甚少。因此,我们建议研究这个问题,并检验中枢神经系统中淋巴管的缺失是主动抑制过程的结果的假设。我们认为,中枢神经系统淋巴管的抑制是通过Sema3F与NRP2的结合来介导的,NRP2可以阻断血管内皮生长因子C和血管内皮生长因子D的促淋巴效应。我们建议通过以下三个目标来检验这一假说。(1)检测Sema3F、NRP2和VEGF-C在视网膜中的表达,进一步研究视网膜淋巴样结构。将通过原位杂交在出生后的小鼠和成人的视网膜中检测Sema3F和3B。将使用NRP2-LacZ小鼠和原位杂交来评估NRP2的表达。随着时间的推移,将对淋巴样结构进行检查,从P0开始,并将评估其他淋巴标志物的表达,包括NRP2、VEGFR3、PodoPlanin和Prox-1。(2)确定阻断Sema3F是否导致视网膜淋巴管的形成。给予可溶性NRP2或中和Sema3F可中和Sema3F的作用。此外,还将评估血管内皮生长因子-C过度表达的影响。(3)确定Sema3F能否抑制角膜炎症/伤口愈合模型中淋巴管的生成。Sema3F阻断视网膜外淋巴管形成的能力将通过在具有良好特征的角膜缝合模型中注射Sema3F蛋白来检验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patricia Ann D'Amore其他文献

Patricia Ann D'Amore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patricia Ann D'Amore', 18)}}的其他基金

Investigation of endomucin as a novel regulator of angiogenesis
内粘蛋白作为血管生成的新型调节剂的研究
  • 批准号:
    9414681
  • 财政年份:
    2017
  • 资助金额:
    $ 30.35万
  • 项目类别:
Investigation of endomucin as a novel regulator of angiogenesis
内粘蛋白作为血管生成的新型调节剂的研究
  • 批准号:
    10219259
  • 财政年份:
    2017
  • 资助金额:
    $ 30.35万
  • 项目类别:
Investigation of endomucin as a novel regulator of angiogenesis
内粘蛋白作为血管生成的新型调节剂的研究
  • 批准号:
    10456724
  • 财政年份:
    2017
  • 资助金额:
    $ 30.35万
  • 项目类别:
Investigation of endomucin as a novel regulator of angiogenesis
内粘蛋白作为血管生成的新型调节剂的研究
  • 批准号:
    9238401
  • 财政年份:
    2017
  • 资助金额:
    $ 30.35万
  • 项目类别:
Fourth Biennial AMD Symposium
第四届AMD双年研讨会
  • 批准号:
    9193821
  • 财政年份:
    2016
  • 资助金额:
    $ 30.35万
  • 项目类别:
Third Biennial Symposium on Age Related Macular Degeneration
第三届年龄相关性黄斑变性双年研讨会
  • 批准号:
    8783667
  • 财政年份:
    2014
  • 资助金额:
    $ 30.35万
  • 项目类别:
Transmission Electron Microscope
透射电子显微镜
  • 批准号:
    8052990
  • 财政年份:
    2011
  • 资助金额:
    $ 30.35万
  • 项目类别:
Mechanisms That Mediate The Absence of Lymphatics in the Retina
调节视网膜淋巴管缺失的机制
  • 批准号:
    7618416
  • 财政年份:
    2008
  • 资助金额:
    $ 30.35万
  • 项目类别:
Role of RPE-derived VEGF in Choroid Development and Stability
RPE 衍生的 VEGF 在脉络膜发育和稳定性中的作用
  • 批准号:
    7060810
  • 财政年份:
    2004
  • 资助金额:
    $ 30.35万
  • 项目类别:
Role of RPE-derived VEGF in Choroid Development and Stability
RPE 衍生的 VEGF 在脉络膜发育和稳定性中的作用
  • 批准号:
    8019446
  • 财政年份:
    2004
  • 资助金额:
    $ 30.35万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 30.35万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 30.35万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 30.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 30.35万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 30.35万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 30.35万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 30.35万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 30.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 30.35万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 30.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了